유전자 발현 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 프로세스별, 제품별, 용량별, 용도별, 기술별, 지역별, 경쟁별(2020-2030년)

Gene Expression Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Process, By Product, By Capacity, By Application, By Technique, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 유전자 발현 시장은 2024년에 157억 8,000만 달러로 평가되었으며, 2030년까지 CAGR 5.58%로 성장하여 218억 6,000만 달러에 달할 것으로 예측됩니다.

유전자 발현은 DNA에 저장된 유전 정보가 기능적인 유전자 산물(주로 단백질과 RNA 분자)로 변환되는 기본적인 세포 과정을 의미하며, 이를 통해 특정 세포 특성 및 기능이 결정됩니다. 유전체 연구 및 시퀀싱 기술의 지속적인 발전, 정밀한 진단 및 예후 도구를 필요로 하는 만성질환 및 감염성 질환의 전 세계 발생률 증가, 새로운 치료법 발견을 위한 바이오의약품 연구개발에 대한 투자 확대로 인해 시장 확대가 가속화되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	157억 8,000만 달러
시장 규모 : 2030년	218억 6,000만 달러
CAGR : 2025-2030년	5.58%
가장 빠르게 성장하는 부문	키트 및 시약
최대 시장	북미

주요 시장 촉진요인

세계 유전자 발현 시장은 혁신의 기반이 되는 촉매제 역할을 하는 유전체학 및 생명공학의 지속적인 발전에 의해 큰 영향을 받고 있습니다. 이러한 발전에는 첨단 시퀀싱 기술, CRISPR과 같은 정교한 유전자 편집 도구, 종합적인 오믹스 접근법이 포함되며, 이 모든 것이 유전자 발현 분석의 깊이와 효율을 높이고 있습니다.

주요 시장 과제

세계 유전자 발현 시장의 성장을 가로막는 가장 큰 문제는 고급 분석 플랫폼에 필요한 막대한 자본 지출입니다. 하이스루풋 시퀀싱 기술 도입과 복잡한 바이오인포매틱스 인프라 구축에는 막대한 선행 투자가 필요합니다.

주요 시장 동향

공간 트랜스크립틱스의 확장은 중요한 문맥 정보를 제공하고, 생체 조직의 미세 환경 내 유전자 활성의 가시화를 가능하게함으로써 유전자 발현 분석에 큰 진전을 가져왔습니다. 이 능력은 복잡한 질병 기전 규명, 정밀한 치료 표적 발굴, 바이오마커 발굴에 필수적입니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 유전자 발현 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 프로세스별(검체 채취, 정제, cDNA 합성·변환, PCR 해석, 데이터 분석·해석)
  • 제품별(키트·시약, DNA 칩, 기타)
  • 용량별(저-중 플렉스, 고플렉스)
  • 용도별(Drug Discovery & Development, 임상 진단, 바이오테크놀러지·미생물학, 기타)
  • 기술별(RNA 발현, 프로모터 해석, 단백질 발현 및 번역 후 변성 해석)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 유전자 발현 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 유전자 발현 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 유전자 발현 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 유전자 발현 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 유전자 발현 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 유전자 발현 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Catalent, Inc.
• Quest Diagnostics Incorporated
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Luminex Corporation
• Takara Bio USA, Inc.
• Danaher Corporation

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Gene Expression Market, valued at USD 15.78 Billion in 2024, is projected to experience a CAGR of 5.58% to reach USD 21.86 Billion by 2030. Gene expression delineates the fundamental cellular process whereby genetic information from DNA is converted into functional gene products, primarily proteins or RNA molecules, thereby dictating specific cellular attributes and functions. The market's expansion is significantly propelled by continuous advancements in genomic research and sequencing technologies, the escalating global incidence of chronic and infectious diseases necessitating precise diagnostic and prognostic tools, and growing investments in biopharmaceutical research and development for novel therapeutic discovery.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 15.78 Billion
Market Size 2030	USD 21.86 Billion
CAGR 2025-2030	5.58%
Fastest Growing Segment	Kits & Reagents
Largest Market	North America

Key Market Drivers

The global gene expression market is significantly influenced by continued advancements in genomics and biotechnology, which serve as foundational catalysts for innovation. These developments encompass sophisticated sequencing technologies, refined gene editing tools such as CRISPR, and comprehensive omics approaches, all of which enhance the depth and efficiency of gene expression analysis. This continuous evolution in scientific capabilities enables researchers to explore complex biological systems with unprecedented resolution, driving the discovery of new therapeutic targets and diagnostic biomarkers.

Key Market Challenges

A significant challenge impeding the growth of the Global Gene Expression Market is the substantial capital outlay required for advanced analysis platforms. Implementing high-throughput sequencing technologies and establishing complex bioinformatics infrastructure necessitates considerable upfront investment. This financial burden restricts broader adoption, particularly among smaller research entities, emerging biotechnology firms, and academic laboratories operating with limited budgets. Such high initial and ongoing maintenance costs can delay or prevent these organizations from acquiring essential equipment and developing the necessary expertise, thereby hindering the widespread application of gene expression technologies across various research and clinical domains.

Key Market Trends

The expansion of spatial transcriptomics significantly advances gene expression analysis by offering critical contextual information, enabling visualization of gene activity within its native tissue microenvironment. This capability is essential for unraveling intricate disease mechanisms, identifying precise therapeutic targets, and discovering biomarkers. Spatial transcriptomics provides insights into cellular heterogeneity and cell-to-cell interactions, fostering notable market growth. For instance, in June 2024, Moleculent AB secured USD 25.0 million in Series A financing to advance its spatial mapping of cell-cell communication. This development is supported by broader industry investment, with the European Federation of Pharmaceutical Industries and Associations reporting an estimated €50,000 million invested in research and development in Europe in 2023.

Key Market Players

• Catalent, Inc.
• Quest Diagnostics Incorporated
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Luminex Corporation
• Takara Bio USA, Inc.
• Danaher Corporation

Report Scope:

In this report, the Global Gene Expression Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Expression Market, By Process:

• Sample Collection
• Purification
• cDNA synthesis & conversion
• PCR Analysis
• Data analysis & interpretation

Gene Expression Market, By Product:

• Kits & Reagents
• DNA Chips
• Others

Gene Expression Market, By Capacity:

• Low- to Mid- Plex
• High-Plex

Gene Expression Market, By Application:

• Drug Discovery & Development
• Clinical Diagnostics
• Biotech & Microbiology
• Others

Gene Expression Market, By Technique:

• RNA Expression
• Promoter Analysis
• Protein Expression& Posttranslational Modification Analysis

Gene Expression Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Gene Expression Market.

Available Customizations:

Global Gene Expression Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Expression Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Process (Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation)
  • 5.2.2. By Product (Kits & Reagents, DNA Chips, Others)
  • 5.2.3. By Capacity (Low- to Mid- Plex, High-Plex)
  • 5.2.4. By Application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others)
  • 5.2.5. By Technique (RNA Expression, Promoter Analysis, Protein Expression& Posttranslational Modification Analysis)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Gene Expression Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Process
  • 6.2.2. By Product
  • 6.2.3. By Capacity
  • 6.2.4. By Application
  • 6.2.5. By Technique
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gene Expression Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Process
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Capacity
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By Technique
  • 6.3.2. Canada Gene Expression Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Process
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Capacity
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By Technique
  • 6.3.3. Mexico Gene Expression Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Process
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Capacity
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By Technique

7. Europe Gene Expression Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Process
  • 7.2.2. By Product
  • 7.2.3. By Capacity
  • 7.2.4. By Application
  • 7.2.5. By Technique
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gene Expression Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Process
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Capacity
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By Technique
  • 7.3.2. France Gene Expression Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Process
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Capacity
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By Technique
  • 7.3.3. United Kingdom Gene Expression Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Process
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Capacity
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By Technique
  • 7.3.4. Italy Gene Expression Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Process
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Capacity
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By Technique
  • 7.3.5. Spain Gene Expression Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Process
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Capacity
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By Technique

8. Asia Pacific Gene Expression Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Process
  • 8.2.2. By Product
  • 8.2.3. By Capacity
  • 8.2.4. By Application
  • 8.2.5. By Technique
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Gene Expression Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Process
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Capacity
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By Technique
  • 8.3.2. India Gene Expression Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Process
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Capacity
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By Technique
  • 8.3.3. Japan Gene Expression Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Process
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Capacity
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By Technique
  • 8.3.4. South Korea Gene Expression Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Process
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Capacity
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By Technique
  • 8.3.5. Australia Gene Expression Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Process
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Capacity
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By Technique

9. Middle East & Africa Gene Expression Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Process
  • 9.2.2. By Product
  • 9.2.3. By Capacity
  • 9.2.4. By Application
  • 9.2.5. By Technique
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Gene Expression Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Process
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Capacity
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By Technique
  • 9.3.2. UAE Gene Expression Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Process
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Capacity
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By Technique
  • 9.3.3. South Africa Gene Expression Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Process
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Capacity
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By Technique

10. South America Gene Expression Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Process
  • 10.2.2. By Product
  • 10.2.3. By Capacity
  • 10.2.4. By Application
  • 10.2.5. By Technique
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Gene Expression Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Process
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Capacity
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By Technique
  • 10.3.2. Colombia Gene Expression Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Process
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Capacity
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By Technique
  • 10.3.3. Argentina Gene Expression Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Process
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Capacity
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By Technique

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Gene Expression Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Catalent, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Quest Diagnostics Incorporated
• 15.3. F. Hoffmann-La Roche Ltd
• 15.4. Illumina, Inc.
• 15.5. PerkinElmer, Inc.
• 15.6. Thermo Fisher Scientific, Inc.
• 15.7. Promega Corporation
• 15.8. Luminex Corporation
• 15.9. Takara Bio USA, Inc.
• 15.10. Danaher Corporation

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료